LG Chem
LG Chem
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT06947499 | |
| Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule | Nutritional and Metabolic Diseases, hyperphosphatemia, metabolic disease, phosphorus metabolism disease | Recruiting | Not stated | 2026-09-03 | NCT06206135 | |
| Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET). | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, female infertility, female reproductive system disorder, infertility disorder | Active, not recruiting | Phase 4 | 2026-09-02 | NCT06921395 | |
| A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, esophageal cancer, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, head and neck cancer, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, small cell lung carcinoma, uterine disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-07 | NCT07752875 | |
| A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty | central precocious puberty, endocrine system disorder, gonadal disorder, precocious puberty | Recruiting | Phase 4 | 2026-07-29 | NCT07710430 | |
| Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, kidney cancer, kidney disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Recruiting | Phase 1 | 2025-11-24 | NCT06332755 | |
| Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children | Bone Diseases, Developmental, Bone Diseases, Endocrine, Cardiovascular Abnormalities, Chronic Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Dwarfism, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sex Chromosome Disorders, Turner syndrome, Urogenital Abnormalities, Urogenital Diseases, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, chromosomal disorder, chronic renal failure syndrome, congenital heart disease, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, heart disorder, hereditary disease, hypopituitarism, hypothalamic disorder, kidney disorder, kidney failure, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder, sex chromosome disorder of sex development, urinary system disorder | Recruiting | Not stated | 2021-02-21 | NCT01604395 |